1 / 59

Breast Conference 9/7/2011

Breast Conference 9/7/2011. LP. 60 AAF presenting with a left breast mass. LP. Menarche: 13y G3P2 (15y), breastfeeding: none OCP: 21y HRT: none Postmenopausal (55y) Hx breast bx: none Hx breast Ca: none Fhx: father – multiple myeloma (60y), sister – renal cell carcinoma Shx:

hannah-long
Download Presentation

Breast Conference 9/7/2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Breast Conference 9/7/2011

  2. LP • 60 AAF presenting with a left breast mass

  3. LP Menarche: 13y G3P2 (15y), breastfeeding: none OCP: 21y HRT: none Postmenopausal (55y) Hx breast bx: none Hx breast Ca: none Fhx: father – multiple myeloma (60y), sister – renal cell carcinoma Shx: caffeine (rarely), soy(-), tobacco (past smoker), ETOH (rarely)

  4. LP PMH: s/p MI PSH: Unilateral oophorectomy d/t ectopic pregnancy Meds: Singulair, Albuterol, Lisinopril NKDA

  5. LP PE: Right breast: Within normal limits Left breast: Nipple areolar complex replaced by tumor Central 4 cm mass Left axillary adenopathy

  6. LP Radiology: Diagnostic mammogram: Left breast: mass with a spiculated margin central to the nipple in the retroareolar region Left axilla: multiple enlarged nodes US: Left breast: 3.9*3.1*2.4cm irregular mass central to the nipple. Adjacent 2.1*1.3*2cm oval mass Left axilla: multiple enlarged nodes, hypoechoic with no fatty hilum

  7. LP Radiology: MRI: Scheduled PET/CT: Scheduled

  8. LP

  9. LP

  10. LP

  11. LP Pathology: Breast lesion: infilrating ductal carcinoma, grade 3 ER, PR, HER2 - pending Axillary lesion: Metastatic ductal carcinoma

  12. LP • 60 F clinical stage IIIB, T4bN1M0

  13. LP

  14. LP • Surgery – • Mastectomy + ALND • Medical oncology – • Neoadjuvant chemotherapy • Radiation oncology – • Plastic surgery – • Genetics – • Psychosocial –

  15. GM • 68 AAF presenting with an abnormal mammogram

  16. GM Menarche: 11y G8P5 (19y), breastfeeding: 1 month OCP: none HRT: none Postmenopausal Hx breast Ca: none Fhx: none Shx: caffeine(+), soy(-), tobacco(-), ETOH(-) Bra: 44C

  17. GM PMH: HTN, DM, GERD, uterine fibroids PSH: none Meds: Nexium, Cozaar, NovoLog, Lantus NKDA

  18. GM PE: Right breast: Palpable mass, 9 o’clock 8cm from nipple Left breast: Within normal limits No axillary, supraclavicular or cervical lymphadenopathy

  19. GM Radiology: Screening mammogram: Right breast: Cluster of masses at 9 o’clock middle depth US: Right breast: irregular hypoechoic mass, 9 o’clock, 13cm from nipple, 1.1*1.4*1cm, with an adjacent 0.5*0.6 cm posterior mass No axillary adenopathy

  20. GM

  21. GM

  22. GM

  23. GM

  24. GM Pathology: Right breast lesion: Infiltrating ductal carcinoma, grade 2 ER(+) PR(+), HER2(-)

  25. GM • 68 F, clinical stage IA/IIA T1c/2N0M0

  26. GM • Surgery – • Partial mastectomy vs. mastectomy + SLNB • Medical oncology – • Radiation oncology – • Plastic surgery – • Genetics – • Psychosocial –

  27. DH • 77 AAF presenting with an abnormal mammogram

  28. DH Menarche: 14y G8P8 (17y) Postmenopausal (early 40’s) Hx breast bx: none Hx breast Ca: none Fhx: son – colon cancer (33y) Shx: tobacco (+), ETOH(-) Bra: C

  29. DH PMH: HTN, PVD, HLD, DM PSH: s/p Whipple procedure 5/2011 – serous cystadenoma Complicated by anastomotic leak s/p colon resection d/t cancer – 1982 AAA Thyroid nodules s/p hysterectomy Meds: Amlodipine, Clonidine, Creon, Colace, Lisinopril, Omeprazole, Pravastatin Allergies: Talwin, Aspirin

  30. DH PE: Nodularity over right thyroid lobe Right breast: Palpable mobile mass 5-6 o’clock, nipple inversion Left breast: Within normal limits No axillary, supraclavicular or cervical lymphadenopathy

  31. DH Radiology: CT: Right breast: 1.5cm nodule, medial aspect Diagnostic mammogram: Benign bilateral calcifications Right breast: round mass with a spiculated margin 5 o’clock Density – 10 o’clock US: Right breast: 1.7*1.9*1.2cm lesion, 5 o’clock, 4cm from nipple, two 6 and 9mm satellite nodules Cluster of lymph nodes 10 o’clock Thyroid: multinodular goiter

  32. DH

  33. DH

  34. DH

  35. DH

  36. DH Pathology: Breast lesion 5 o’clock: Invasive mucinous carcinoma ER(+) PR(-), HER2(+1) Grade 2

  37. DH • 77 F, clinical stage IA, T1cN0M0 mucinous carcinoma

  38. DH

  39. DH • Surgery – • Biopsy of 10 o’clock lesion • Partial mastectomy vs. mastectomy + SLNB • Medical oncology – • Radiation oncology – • Plastic surgery – • Genetics – • Psychosocial –

  40. SS • 52 AAF presenting with a mass on left mastectomy scar • 1994 – • T2N0M0 Left breast lobular carcinoma • ER/PR+, HER2 unknown • Modified radical mastectomy, reconstruction • Chemotherapy

  41. SS Menarche: 12y G3P3 (14y), breastfeeding: none OCP: none HRT: none Postmenopausal (51y) Fhx: none Shx: caffeine(+), tobacco(+) Bra: 44D

  42. SS PMH: DM, HTN, HLD, CRF, arthritis PSH: MRM + reconstruction (saline implant) - 1994 right breast reduction – 1997 Colectomy – 1997 Meds: Metformin, Avandia, Prilosec, Ditropan, Naproxen, Percocet, Lisinopril Allergies - Compazine

  43. SS PE: Right breast: s/p reduction mammoplasty Left breast: s/p mastectomy, reconstruction s/p excisional biopsy No axillary, supraclavicular or cervical lymphadenopathy

  44. SS Radiology: Diagnostic mammogram: 4/2011 – no significant abnormalities US: 4/2011 - no significant abnormalities MRI: Limited exam PET/CT: no evidence of metastasis

  45. SS Pathology: Breast lesion (excisional biopsy): Infiltrating lobular carcinoma 2.8cm Involving dermis and subcutaneous tissues Positive margins ER(+) PR(+), HER2(+2, -FISH)

  46. SS • 52 F, recurrent lobular carcinoma, left breast

  47. SS • Surgery – • Resection • Medical oncology – • Radiation oncology – • Plastic surgery – • Implant removal • Genetics – • Psychosocial –

  48. Concepts in ALND • Contribution of local therapy to breast cancer survival is controversial • Biological factors may effect selective invasion to lymph nodes rather than visceral organs • Lymph node tumor status influences but not dictates chemotherapy • Earlier detection reduces incidence and number of nodal metastases

  49. Is axillary lymph node dissection really necessary? • Aim: determine the effects of ALND on overall survival in patients with SLN metastases treated with lumpectomy, adjuvant systemic therapy and radiation • Multicenter randomized phase 3 trial

  50. Inclusion: • Adult women • Histologically confirmed invasive breast carcinoma • Clinically 5cm or less • No palpable adenopathy • SLN containing metastatic breast cancer (FS, touch or H&E) • Lumpectomy to negative margins

More Related